Kainos Partners is proud to announce that we are now part of AssuredPartners. After joining the company in February 2021, we are taking steps to align with the identity and culture of our parent company, AssuredPartners. While this change means we have national resources available to us, we still operate locally offering the personal touch that you have come to expect and you will continue working with the account team you know and trust. We are committed to providing Power through Partnership. Learn more at AssuredPartners.com

Pharmacy & 340B


Pharmacy claims continue to make up a large portion of the overall dollars spent by employers in their medical programs, often in excess of 20%. 

Too often the pharmacy benefit manager (PBM) is not analyzed properly to ensure you are receiving not only the best possible pricing, but also the best leverage of pharmacy data for disease management purposes. 

Anyone who has spent much time evaluating PBM’s knows that there is often very little transparency in regard to where your money actually goes, especially in regard to rebates.

We believe your first goal should be to ensure you have the best possible prescription drug pricing in the market, and to push towards as much transparency as possible.  Then once you have the best pricing, it is critical that you use the data gathered in you overall population health management efforts.

The 340B drug pricing program offers a great opportunity to qualified disproportionate share hospitals.  There are also many other organizations potentially eligible, such as federally qualified health centers.  If you fall into this category of eligibility, you could be eligible for significant savings on your prescription drug costs.